Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.97 |
| ▸ | MAOB | P27338 | 2/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.64 |
| ▸ | PGR | P06401 | 1/20 | 0.64 |
| ▸ | HTR1A | P08908 | 1/20 | 0.64 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | DRD3 | P35462 | 1/20 | 0.64 |
| ▸ | SNCA | P37840 | 1/20 | 0.64 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 9/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 3/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coenzyme Q2 SCHEMBL623496 | 1.00 | LMNA (0.97) | LMNAMAOBPTGS1PGRHTR1A | |
| SCHEMBL5530210 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Ubidecarenone SCHEMBL19858 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Coenzyme Q4 SCHEMBL6279406 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Ubidecarenone SCHEMBL13026488 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| SCHEMBL16393869 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| SCHEMBL9975753 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Ubidecarenone SCHEMBL11901691 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| Coenzyme Q4 SCHEMBL6279408 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A | |
| SCHEMBL29402769 | 0.99 | LMNA (1.00) | LMNAMAOBPTGS1PGRHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110059898-A1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | CANCURE LIMITED (AU) | 2011-03-10 | — | — | US | claimed |
| EP-2063884-A1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | Ralph, John Stephen (AU) | 2009-06-03 | — | — | EP | claimed |
| WO-2008031171-A1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | UNIV GRIFFITH (AU) | 2008-03-20 | — | — | WO | claimed |
| US-11945862-B2 | Compositions and methods for antibody production | IMMUNOGEN, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| US-20220204650-A1 | SYSTEMS AND METHODS FOR IMMOBILIZING A TARGET PROTEIN | UNIVERSITY OF SOUTH FLORIDA (US) | 2022-06-30 | — | — | US | disclosed |
| US-20210130457-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | IMMUNOGEN, INC | 2021-05-06 | — | — | US | disclosed |
| US-10913795-B2 | Compositions and methods for antibody production | IMMUNOGEN, INC. (US) | 2021-02-09 | — | — | US | disclosed |
| US-20190119374-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | IMMUNOGEN, INC. | 2019-04-25 | — | — | US | disclosed |
| US-20170002393-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | IMMUNOGEN, INC. (US) | 2017-01-05 | — | — | US | disclosed |
| EP-3077522-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | Immunogen, Inc. (US) | 2016-10-12 | — | — | EP | disclosed |
| WO-2015085003-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | IMMUNOGEN, INC. (US) | 2015-06-11 | — | — | WO | disclosed |
| EP-2063884-B1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | RALPH STEPHEN JOHN (AU) | 2014-08-13 | — | — | EP | disclosed |
| US-8410056-B2 | Pro-oxidant anti-cancer compounds | CANCURE LIMITED (AU) | 2013-04-02 | — | — | US | disclosed |
| US-20110059898-A1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | CANCURE LIMITED (AU) | 2011-03-10 | — | — | US | disclosed |
| EP-2063884-A1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | Ralph, John Stephen (AU) | 2009-06-03 | — | — | EP | disclosed |
| WO-2008031171-A1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | UNIV GRIFFITH (AU) | 2008-03-20 | — | — | WO | disclosed |
| US-6635802-B1 | Culturing mammalian cell population in serum starvation media containing apoptosis inhibitor to increase number of cells at G0/G1 stage of cell cycle within cell population, increasing number of nuclear transfer competent cells | THE TEXAS A&M UNIVERSITY SYSTEM | 2003-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190119374-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | TXNRD1, P4HB, CYBB | LMNA 3496/4885MAOB 2560/4885PTGS1 1016/4885 |
| US-11945862-B2 | Compositions and methods for antibody production | TXNRD1, P4HB, CYBB | LMNA 3496/4885MAOB 2560/4885PTGS1 1016/4885 |
| US-10913795-B2 | Compositions and methods for antibody production | TXNRD1, P4HB, CYBB | LMNA 3496/4885MAOB 2560/4885PTGS1 1016/4885 |
| US-20210130457-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | TXNRD1, P4HB, CYBB | LMNA 3496/4885MAOB 2560/4885PTGS1 1016/4885 |
| US-20110059898-A1 | PRO-OXIDANT ANTI-CANCER COMPOUNDS | PRDX5, MT-ND2, UQCRC2 | LMNA 550/4885MAOB 2940/4885PTGS1 347/4885 |
| US-20170002393-A1 | COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION | TXNRD1, P4HB, CYBB | LMNA 3496/4885MAOB 2560/4885PTGS1 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.